Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content
ERRATUM:  Weeks 1-52 data for Haemophilus influenzae, invasive disease in Table 1 were updated on Monday, February 11, 2019.
Labels for "Nontypeable" and "Non-b serotype" were incorrectly placed resulting in the numbers being switched for these two rows. They are now correct.

National Notifiable Infectious Diseases: Weekly Tables

TABLE 1. Weekly cases* of selected infrequently reported notifiable diseases (<1,000 cases reported during the preceding year), excluding U.S. territories -- United States, week ending March 24, 2018 (WEEK 12) †
Disease Total cases reported for previous years
Current
week
Cum
2018
5-year
weekly
average§
2017 2016 2015 2014 2013 States reporting cases
during current week (Count)
Anthrax - - - - - - - -  
Arboviral diseases, neuroinvasive and non-neuroinvasive ¶                  
Chikungunya virus disease - 5 2 144 247 896 NN NN  
Eastern equine encephalitis virus disease - - 0 4 7 6 8 8  
Jamestown Canyon virus disease - - 0 70 15 11 11 22  
La Crosse virus disease - - 0 61 35 55 80 85  
Powassan virus disease - - 0 33 22 7 8 12  
St. Louis encephalitis virus disease - - 0 11 8 23 10 1  
Western equine encephalitis virus disease - - - - - - - -  
Botulism                  
Total - 26 3 149 201 195 161 152  
Foodborne - 2 0 16 31 37 15 4  
Infant - 22 3 116 144 138 127 136  
Other (wound and unspecified) - 2 1 17 26 20 19 12  
Brucellosis 1 8 2 122 127 126 92 99 CO (1 )
Chancroid - 1 0 7 11 11 - -  
Cholera - - 0 4 15 5 5 14  
Cyclosporiasis ¶ - 6 1 1,120 535 645 388 784  
Diphtheria - - - - - - 1 -  
Haemophilus influenzae,
invasive disease (age <5 years)
                 
Serotype b - 3 1 25 30 29 40 31  
Non-b serotype - 30 3 153 159 135 266 233  
Nontypeable 1 31 4 140 196 175 128 141 TX (1 )
Unknown serotype 4 68 4 254 187 167 39 34 MA (1 ), FL (1 ), TX (1 ), ID (1 )
Hansen's disease ¶ - 4 1 107 78 89 88 81  
Hantavirus infection, non-hantavirus pulmonary syndrome ¶ - - - - 6 3 NN NN  
Hantavirus pulmonary syndrome ¶ - 2 0 12 31 21 32 21  
Hemolytic uremic syndrome, post-diarrheal ¶ - 6 3 291 307 274 250 329  
Hepatitis B, perinatal infection - 2 1 31 34 37 47 48  
Influenza-associated pediatric mortality ¶, ** 4 126 5 110 82 130 141 160 SD (1 ), MS (1 ), TX (1 ), NM (1 )
Leptospirosis ¶ 2 11 1 58 78 40 38 NN MD (1 ), OR (1 )
Listeriosis 3 85 9 836 786 768 769 735 NY (1 ), NYC (1 ), OH (1 )
Measles †† 1 22 3 122 85 188 667 187 FL (1 )
Meningococcal disease                  
Serogroups ACWY - 21 3 77 126 120 123 142  
Serogroup B 1 9 3 69 86 111 89 99 WA (1 )
Other serogroups - 3 1 19 21 21 25 17  
Unknown serogroup 3 52 5 187 142 120 196 298 NY (2 ), GA (1 )
Novel influenza A virus infections §§ - - - 67 23 7 3 21  
Paratyphoid fever ¶¶ - 3 NA NA NA NA NA NA  
Plague - - - 1 4 16 10 4  
Poliomyelitis, paralytic - - - - - - - 1  
Polio virus infection, nonparalytic ¶ - - - - - - - -  
Psittacosis ¶ - - 0 5 12 4 8 6  
Q fever ¶                  
Total - 11 3 150 164 156 168 170  
Acute - 8 2 117 132 122 132 137  
Chronic - 3 1 33 32 34 36 33  
Rabies, human - 1 0 2 - 2 1 2  
Severe acute respiratory syndrome-associated coronavirus disease (SARS CoV) - - - - - - - -  
Smallpox - - - - - - - -  
Streptococcal toxic shock syndrome ¶ - 66 7 337 283 335 259 224  
Syphilis, congenital - 75 9 749 633 493 458 348  
Toxic shock syndrome (other than streptococcal) ¶ 2 2 1 26 40 64 59 71 TN (1 ), AR (1 )
Trichinellosis ¶ - - 0 8 26 14 14 22  
Tularemia - 2 1 214 230 314 180 203  
Typhoid fever - 45 6 339 376 367 349 338  
Vancomycin-intermediate Staphylococcus aureus - 8 4 104 108 183 212 248  
Vancomycin-resistant Staphylococcus aureus - - 0 - - 3 - -  
Viral hemorrhagic fevers ***                  
Crimean-Congo hemorrhagic fever virus - - - - - - NP NP  
Ebola virus - - - - - - 4 NP  
Guanarito virus - - - - - - NP NP  
Junin virus - - - - - - NP NP  
Lassa virus - - - - - 1 1 NP  
Lujo virus - - - - - - NP NP  
Machupo virus - - - - - - NP NP  
Marburg virus - - - - - - NP NP  
Sabia virus - - - - - - NP NP  
Yellow fever - - - - - - - -  
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NA: Not available — CDC does not have data because of nomenclature changes in how data are reported for nationally notifiable conditions.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2017 and 2018 are provisional and subject to change. Data for years 2013 through 2016 are finalized.
  • † This table does not include cases from the U.S. territories.
  • § Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. Additional information is available at https://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf.
  • ¶ Not reportable in all jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated pediatric mortality. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html.
  • ** Since October 1, 2017, 137 influenza-associated pediatric deaths occurring during the 2017-18 season have been reported.
  • †† The one measles case reported for the current week was indigenous.
  • §§ Novel influenza A virus infections are human infections with influenza A viruses that are different from currently circulating human seasonal influenza viruses. With the exception of one avian lineage influenza A (H7N2) virus, all novel influenza A virus infections reported to CDC since 2013 have been variant influenza viruses.
  • ¶¶ Prior to 2018, cases of paratyphoid fever were included with salmonellosis cases (see Table II).
  • *** Prior to 2015, CDC's National Notifiable Diseases Surveillance System (NNDSS) did not receive electronic data about incident cases of specific viral hemorrhagic fevers; instead data were collected in aggregate as "viral hemorrhagic fevers'. NNDSS was updated beginning in 2015 to receive data for each of the viral hemorrhagic fevers listed.

TOP